PortfoliosLab logo
TMDX vs. NVDA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TMDX and NVDA is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

TMDX vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TransMedics Group, Inc. (TMDX) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

TMDX:

-0.10

NVDA:

0.38

Sortino Ratio

TMDX:

0.26

NVDA:

0.84

Omega Ratio

TMDX:

1.04

NVDA:

1.11

Calmar Ratio

TMDX:

-0.16

NVDA:

0.51

Martin Ratio

TMDX:

-0.25

NVDA:

1.24

Ulcer Index

TMDX:

43.39%

NVDA:

15.09%

Daily Std Dev

TMDX:

69.15%

NVDA:

58.96%

Max Drawdown

TMDX:

-73.69%

NVDA:

-89.73%

Current Drawdown

TMDX:

-27.82%

NVDA:

-9.56%

Fundamentals

Market Cap

TMDX:

$4.33B

NVDA:

$3.39T

EPS

TMDX:

$1.41

NVDA:

$3.01

PE Ratio

TMDX:

90.16

NVDA:

44.89

PS Ratio

TMDX:

8.86

NVDA:

22.86

PB Ratio

TMDX:

16.22

NVDA:

39.31

Total Revenue (TTM)

TMDX:

$488.23M

NVDA:

$148.52B

Gross Profit (TTM)

TMDX:

$290.25M

NVDA:

$104.12B

EBITDA (TTM)

TMDX:

$82.66M

NVDA:

$90.97B

Returns By Period

In the year-to-date period, TMDX achieves a 103.88% return, which is significantly higher than NVDA's 0.63% return.


TMDX

YTD

103.88%

1M

40.54%

6M

46.60%

1Y

-6.80%

3Y*

63.34%

5Y*

57.28%

10Y*

N/A

NVDA

YTD

0.63%

1M

21.07%

6M

-2.24%

1Y

23.29%

3Y*

93.53%

5Y*

72.51%

10Y*

74.01%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


TransMedics Group, Inc.

NVIDIA Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

TMDX vs. NVDA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMDX
The Risk-Adjusted Performance Rank of TMDX is 4343
Overall Rank
The Sharpe Ratio Rank of TMDX is 4545
Sharpe Ratio Rank
The Sortino Ratio Rank of TMDX is 4343
Sortino Ratio Rank
The Omega Ratio Rank of TMDX is 4343
Omega Ratio Rank
The Calmar Ratio Rank of TMDX is 4141
Calmar Ratio Rank
The Martin Ratio Rank of TMDX is 4545
Martin Ratio Rank

NVDA
The Risk-Adjusted Performance Rank of NVDA is 6565
Overall Rank
The Sharpe Ratio Rank of NVDA is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of NVDA is 6060
Sortino Ratio Rank
The Omega Ratio Rank of NVDA is 5959
Omega Ratio Rank
The Calmar Ratio Rank of NVDA is 7272
Calmar Ratio Rank
The Martin Ratio Rank of NVDA is 6666
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TMDX vs. NVDA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current TMDX Sharpe Ratio is -0.10, which is lower than the NVDA Sharpe Ratio of 0.38. The chart below compares the historical Sharpe Ratios of TMDX and NVDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

TMDX vs. NVDA - Dividend Comparison

TMDX has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.


TTM20242023202220212020201920182017201620152014
TMDX
TransMedics Group, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.02%0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%

Drawdowns

TMDX vs. NVDA - Drawdown Comparison

The maximum TMDX drawdown since its inception was -73.69%, smaller than the maximum NVDA drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for TMDX and NVDA.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

TMDX vs. NVDA - Volatility Comparison

TransMedics Group, Inc. (TMDX) has a higher volatility of 19.77% compared to NVIDIA Corporation (NVDA) at 10.81%. This indicates that TMDX's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

TMDX vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between TransMedics Group, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B20212022202320242025
143.54M
44.06B
(TMDX) Total Revenue
(NVDA) Total Revenue
Values in USD except per share items

TMDX vs. NVDA - Profitability Comparison

The chart below illustrates the profitability comparison between TransMedics Group, Inc. and NVIDIA Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%20212022202320242025
61.5%
60.5%
(TMDX) Gross Margin
(NVDA) Gross Margin
TMDX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, TransMedics Group, Inc. reported a gross profit of 88.23M and revenue of 143.54M. Therefore, the gross margin over that period was 61.5%.

NVDA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, NVIDIA Corporation reported a gross profit of 26.67B and revenue of 44.06B. Therefore, the gross margin over that period was 60.5%.

TMDX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, TransMedics Group, Inc. reported an operating income of 27.44M and revenue of 143.54M, resulting in an operating margin of 19.1%.

NVDA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, NVIDIA Corporation reported an operating income of 21.64B and revenue of 44.06B, resulting in an operating margin of 49.1%.

TMDX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, TransMedics Group, Inc. reported a net income of 25.68M and revenue of 143.54M, resulting in a net margin of 17.9%.

NVDA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, NVIDIA Corporation reported a net income of 18.78B and revenue of 44.06B, resulting in a net margin of 42.6%.